After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
ARWR belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Arrowhead Pharmaceuticals Inc. is $3.14B. A total of 0.98 million shares were traded on the day, compared to an average of 1.05M shares.
In the most recent transaction, Oliver Tracie sold 9,394 shares of ARWR for 25.28 per share on Jul 02 ’24. After the transaction, the Chief Commercial Officer now owns 127,107 company shares. In a previous transaction on May 02 ’24, Vakiener Victoria sold 1,799 shares at 23.31 per share. ARWR shares that Director owns now total 30,205.
Among the insiders who sold shares, Hamilton James C disposed of 6,000 shares on Apr 01 ’24 at a per-share price of $28.03. This resulted in the Chief Discovery/Trans Medicine holding 204,851 shares of ARWR after the transaction. In another insider transaction, Lu Hongbo bought 1,000 shares at $28.00 per share on Mar 19 ’24. Company shares held by the Director now total 32,680.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ARWR has a high of $39.83 and a low of $20.67.
As of this writing, ARWR has an earnings estimate of -$1.04 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.02 per share and a lower estimate of -$1.57.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ARWR’s latest balance sheet shows that the firm has $367.79M in Cash & Short Term Investments as of fiscal 2021. There were $25.55M in debt and $146.54M in liabilities at the time. Its Book Value Per Share was $2.66, while its Total Shareholder’s Equity was $408.82M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARWR is Buy with a score of 4.27.
